E
Elliott H. Sohn
Researcher at University of Iowa
Publications - 111
Citations - 5027
Elliott H. Sohn is an academic researcher from University of Iowa. The author has contributed to research in topics: Retinal & Macular degeneration. The author has an hindex of 30, co-authored 101 publications receiving 3717 citations. Previous affiliations of Elliott H. Sohn include University of Iowa Hospitals and Clinics & Williams College.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen R. Russell,Jean Bennett,Jennifer Wellman,Daniel C. Chung,Zi Fan Yu,Amy Tillman,Janet Wittes,Julie Pappas,Okan U. Elci,Sarah McCague,Dominique Cross,Kathleen A. Marshall,Jean Walshire,Taylor Kehoe,Hannah Reichert,Maria C. Davis,Leslie Raffini,Lindsey A. George,F. Parker Hudson,Laura E. Dingfield,Xiaosong Zhu,Julia A. Haller,Elliott H. Sohn,Vinit B. Mahajan,Wanda Pfeifer,Michelle T. Weckmann,Chris A. Johnson,Dina Y. Gewaily,Arlene V. Drack,Edwin M. Stone,Katie Wachtel,Francesca Simonelli,Bart P. Leroy,Bart P. Leroy,J. Fraser Wright,Katherine A. High,Albert M. Maguire +36 more
TL;DR: Voretigene neparvovec gene replacement improved functional vision in RPE65-mediated inherited retinal dystrophy previously medically untreatable.
Journal ArticleDOI
Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.
Elliott H. Sohn,Hille W. van Dijk,Chunhua Jiao,Pauline H. B. Kok,Woojin Jeong,Nazli Demirkaya,Allison Garmager,Ferdinand W. N. M. Wit,Murat Kucukevcilioglu,Mirjam E J van Velthoven,J. Hans DeVries,Robert F. Mullins,Markus H. Kuehn,Reinier O. Schlingemann,Milan Sonka,Frank D. Verbraak,Michael D. Abràmoff +16 more
TL;DR: This longitudinal study in people with diabetes with no or minimal DR shows thatRDN precedes signs of microvasculopathy and that RDN is progressive and independent of glycated hemoglobin, age, and sex and represents a paradigm shift in the understanding of ocular diabetic complications.
Journal ArticleDOI
Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia.
David Sarraf,David Sarraf,Ehsan Rahimy,Ehsan Rahimy,Amani A. Fawzi,Elliott H. Sohn,Irene Barbazetto,David N. Zacks,Robert A. Mittra,James M. Klancnik,Sarah Mrejen,Naomi Goldberg,Robert Beardsley,John A. Sorenson,K. Bailey Freund +14 more
TL;DR: Paracentral acute middle maculopathy may represent a novel variant of AMN that affects the middle layers of the macula above the OPL as diagnosed with SD-OCT imaging and it is proposed that each of these lesions may be explained by occlusion of either the superficial capillary plexus or deep capillaryplexus located in the innermost and outermost portion of the INL.
Journal ArticleDOI
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
Benjamin Bakall,James C. Folk,H. Culver Boldt,Elliott H. Sohn,Edwin M. Stone,Stephen R. Russell,Vinit B. Mahajan,Vinit B. Mahajan +7 more
TL;DR: Aflibercept therapy appears to be beneficial in a subset of patients with neovascular age-related macular degeneration who exhibit recurrent or resistant intraretinal or subretinal fluid following multiple injections with either bevacizumab or ranibizumabs.
Journal ArticleDOI
Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.
S. Scott Whitmore,Elliott H. Sohn,Kathleen R. Chirco,Arlene V. Drack,Edwin M. Stone,Budd A. Tucker,Robert F. Mullins +6 more
TL;DR: The significance of complement activation in AMD, particularly with respect to the formation of the membrane attack complex in the aging choriocapillaris, is discussed and a hypothesis for the pathogenesis of early AMD is presented.